Follow
Generics
A generic drug is developed with the same dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use as a brand-name medication. Generics are known as bioequivalent to the name-brand drug, so they demonstrate the same degree of clinical benefit.
OCT 20, 2021 | 9:00 AM
Date: October 20, 2021 Time: 9:00am PDT Cryo-electron microscopy (cryo-EM) is rapidly evolving to be the primary tool for structure determination of membrane proteins. However, generation of...
OCT 20, 2021 | 9:00 AM
Date: October 20, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Protein therapeutics is one of the major drug modalities in biopharma industry. With more and more elucidation of disease pathology,...
OCT 19, 2021 | 6:00 AM
Date: October 19, 2021 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) Colleen Monaghan will present Hain Lifescience IVD workflows for the latest SARS-CoV-2 diagnostic assays. Rapid respons...
OCT 14, 2021 | 8:00 AM
Date: October 14, 2021 Time: 8:00am (PDT), 11:00am (EDT) The primary role of B cells is to secrete antibodies, boosting our adaptive immune responses, making them an essential part of our im...
OCT 14, 2021 | 7:00 AM
Date: October 14, 2021 Time: 7:00am (PDT), 10:00am (EDT) Heterologous protein expression in model organisms has many applications, including protein engineering, production of industrial enz...
OCT 13, 2021 | 11:55 PM
Vaccination and infection are two different paths to immunity. Understanding human immune responses to SARS-CoV-2 RNA vaccines is of interest for a panoply of reasons. mRNA vaccines have dem...
OCT 13, 2021 | 11:55 PM
Learning Objectives: 1. Discuss the value of infectious disease diagnostics. 2. Recognize the importance of home diagnostics. 3. Identify how better diagnostics leads to more resiliency to p...
OCT 13, 2021 | 4:30 PM
As the pandemic continues to evolve, new tools are needed to fight it. The greatest needs revolve around the ability to screen asymptomatic individuals for COVID-19 and to simultaneously tes...
OCT 13, 2021 | 3:00 PM
Since late 2020, several prominent SARS-CoV-2 variants of concern have emerged, harboring specific mutations which increase viral transmissibility Delta variant) and which appear to reduce t...
OCT 13, 2021 | 1:30 PM
One significant challenge with SARS-CoV-2 wastewater monitoring is the lack of optimized and standardized sample processing steps, from sample collection to RNA detection. Viral concentratio...
OCT 13, 2021 | 1:30 PM
This presentation “SARS-CoV-2 Related Workflow and Solutions: Detection and Genotyping” will focus on strategies for the testing and detection of SARS-CoV-2, including multiplexe...
OCT 13, 2021 | 10:30 AM
By examining the host response to SARS-CoV-2 infection we gain valuable insights into viral pathogenesis and COVID-19 progression. MicroRNAs (miRNAs), a class of small (18-22nt), non-coding...
